Home   About this service   Get the news  
+32 2 743 34 03

 Belgium  Other Countries
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
Gimv [BE0003699130/GIMB]   
[20/09/2017]

Gimv : Gimv acquires 23.6 per cent of Cegeka shares

Antwerp/Hasselt, 20 09 2017, 5:45 PM CET embargo Gimv acquires 23.6 per cent of Cegeka shares Gimv is to take a 23.6 per cent interest in ICT company Cegeka. With this move, Cegeka aims to strengthen its position in existing markets and expand geographically. The ambition is to realise growth both organically and by means of a buy &... See more
 
D'IETEREN [BE0974259880/DIE]   
[19/09/2017]

D'IETEREN : Role Evolutions at Moleskine

PRESS RELEASE: ROLE EVOLUTIONS AT MOLESKINE Tuesday 19 September 2017 – 3:00 pm CET Role Evolutions at Moleskine The Board of directors of Moleskine Srl that will be held on 27 September... See more
 
PHARMASIMPLE [BE0974302342/MLPHA]   
[18/09/2017]

PHARMASIMPLE : Résultats semestriels 2017

Forte hausse de l'activité Poursuite des investissements stratégiques avec maîtrise de la rentabilité Perspectives 2017 prometteuses « Au cours du 1er semestre 2017, nous avons poursuivi la stratégie d'hypercroissance de notre chiffre d'affaires. Malgré d'importants efforts techniques, commerciaux et marketing qui ont accompagné le fort développement de notre... See more
 
TINC [BE0974282148/TINC]   
[18/09/2017]

TINC : Portfolio growth (+38%) enables a higher dividend - Today TINC publishes its annual report 2016-2017

Portfolio growth 38% enables a higher dividend Today TINC publishes its annual report 20162017 Regulated information Antwerp, under embargo until 18 September 2017, 7h30 CET HIGHLIGHTS  The net profit for the financial year... See more
 
UCB [BE0003739530/UCB]   
[15/09/2017]

UCB : UCB Media Room: Briviact FDA monotherapy approval

New indication for BRIVIACT® brivaracetam: UCB’s newest antiepileptic drug approved by FDA as monotherapy treatment of partialonset seizures in adultsBRIVIACT® CV provides a new monotherapy treatment option for epilepsy patients 16 years of age and older with partialonset focal seizures, which can be initiated at a therapeutic dose at day one.Approval applies a newly established regulatory... See more
 
UCB [BE0003739530/UCB]   
[14/09/2017]

UCB : UCB Media Room: New Cimzia findings presented at EADV

New CIMZIA® certolizumab pegol Findings Presented at European Academy of Dermatology and Venereology EADV CongressPresentations included the first 48week data from the CIMPASI1 and CIMPASI2 psoriasis trials, and rerandomized data through 48 weeks from the CIMPACT psoriasis trial 1,2Treatment with CIMZIA was associated with significant and clinically meaningful improvements in quality of life and... See more
 
PHARMASIMPLE [BE0974302342/MLPHA]   
[13/09/2017]

PHARMASIMPLE : Transfert de Pharmasimple sur Euronext Growth (ex-Alternext)

La Louvière Belgique, le 13 septembre 2017, 20h – Pharmasimple, Euronext Growth : ALPHS, BE0974302342, parapharmacie on line majeure en France, a le plaisir d'annoncer le transfert de cotation effectif de ses titres depuis le marché Euronext Access exMarché Libre vers Euronext Growth exAlternext. Cette admission fait suite au succès de la levée de fonds de 5 M€ réalisée... See more
 
D'IETEREN [BE0974259880/DIE]   
[13/09/2017]

D'IETEREN : Repurchase of own shares in the context of the liquidity contract

PRESS RELEASE: REPURCHASE OF OWN SHARES IN THE CONTEXT OF THE LIQUIDITY CONTRACT REGULATED INFORMATION Wednesday 13 September 2017 – 6:00 pm CET Repurchase of own shares in the context... See more
 
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
Currencies
DOLLAR US 17/11 0.8478€ -0.20%
LIVRE STERLING 17/11 1.1187€ -0.23%
FRANC SUISSE 17/11 0.8550€ -0.09%
YEN 17/11 0.0075€ +0.23%

BEL 20 top gainers
UMICORE 18:07 38.500€ +0.35%
DELHAIZE GRO 17:36 102.800€ +0.29%
UMICORE 17:35 75.250€ +0.23%
SOLVAY 17:35 121.050€ +0.04%
D'IETEREN 17:35 38.650€ +0.01%

BEL 20 top losers
KBC 17:35 67.380€ -3.25%
UCB 17:35 61.410€ -2.06%
ELIA 17:35 49.045€ -1.72%
COFINIMMO 17:35 107.450€ -1.33%
TELENET GROU 17:35 58.620€ -1.01%

Videos
Gestionnaires,
Emetteurs,
My favourite companies
Most read news